Organization model |
Creation of a National Ad-hoc REC for COVID-19 research |
Ecuador, Peru |
2 (20%) |
Designation of a National REC for COVID-19 research review |
Brazil, Dominican Republic, Panama |
3 (30%) |
Creation of an Ad-hoc REC for COVID-19 research under specific cases |
Costa Rica |
1 (10%) |
No changes |
Argentina, Chile, Mexico, Colombia |
4 (40%) |
Coordination between stakeholders |
Coordination between RECs |
Brazil,
Chile |
2 (20%) |
Coordination among RECs and other stakeholders (health authorities, NRA) |
Colombia (between RECs and NRA) |
1 (10%) |
Operational guidance |
Members’ availability |
Argentina, Brazil, Chile, Costa Rica (CCSS), Ecuador, Panama, Peru |
7 (70%) |
Emergency ethics training |
Argentina |
1 (10%) |
Call for COVID-19-related experts |
Argentina, Chile, Costa Rica (CCSS), Ecuador, Mexico, Panama, Peru |
7 (70%) |
Virtual meetings |
Argentina, Brazil, Chile, Costa Rica (CCSS), Dominican Republic, Ecuador, Mexico, Peru |
8 (80%) |
Reduced quorum |
Argentina, Brazil, Costa Rica (CCSS) |
3 (30%) |
Use of electronic means |
Argentina, Brazil, Chile, Costa Rica (CCSS), Dominican Republic, Ecuador, Mexico, Peru |
8 (80%) |
Shorter time frames |
Argentina, Brazil, Chile, Costa Rica (CCSS), Dominican Republic, Ecuador, Mexico, Panama, Peru |
9 (90%) |
Use of protocol models |
Chile |
1 (10%) |
Decision-making procedures |
Argentina, Costa Rica (CCSS), Ecuador, Peru |
4 (40%) |
Studies oversight |
Argentina, Brazil, Costa Rica (CCSS), Ecuador, Mexico, Peru |
6 (60%) |
Key ethical issues for review |
The use of alternative informed consent processes |
Argentina, Brazil, Chile, Colombia, Costa Rica, Peru |
6 (60%) |
The collection and store of samples and data for future research |
Argentina, Brazil, Chile, Costa Rica, Ecuador, Peru |
6 (60%) |
Risk mitigation plans |
Argentina, Brazil, Chile, Colombia, Costa Rica, Mexico, Peru |
7 (70%) |
Strategies for community engagement in COVID-19 research |
Costa Rica |
1 (10%) |
Rapid data sharing |
Argentina, Costa Rica, Ecuador, Peru |
4 (40%) |
Equal access to research benefits |
Argentina, Costa Rica, Ecuador, Peru |
4 (40%) |